# Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure

> **NCT02137187** · PHASE3 · UNKNOWN · sponsor: **Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella** · enrollment: 1830 (estimated)

## Conditions studied

- Permanent Atrial Fibrillation

## Interventions

- **PROCEDURE:** AV junction ablation
- **DEVICE:** CRT
- **DRUG:** Optimized drug therapy
- **DEVICE:** ICD

## Key facts

- **NCT ID:** NCT02137187
- **Lead sponsor:** Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10-15
- **Primary completion:** 2021-05-15
- **Final completion:** 2021-07-31
- **Target enrollment:** 1830 (ESTIMATED)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137187, "Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02137187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*